SCHEMBL6276470

SCHEMBL6276470

CCCCCOC(=O)C1c2ccccc2N(C)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
TSHR P16473 3/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAPK1 P28482 1/20 0.48
PPARG P37231 3/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
HSD17B10 Q99714 1/20 0.45
BCHE P06276 1/20 0.43
CHRM2 P08172 6/20 0.42
CHRM1 P11229 6/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005772 0.88 HDAC4 (0.57) HDAC4HDAC7HDAC5TSHRCYP3A4
SCHEMBL2996947 0.84 HDAC4 (0.53) HDAC4HDAC7HDAC5TSHRCYP3A4
SCHEMBL877398 0.82 TSHR (0.53) TSHRTP53CYP3A4MAPK1PPARG
SCHEMBL15505387 0.78 HDAC4 (0.53) HDAC4HDAC7HDAC5TSHRCYP3A4
SCHEMBL21675546 0.78 KMT2A (0.64) TSHRCYP3A4PPARGALDH1A1LMNA
SCHEMBL38661846 0.77 HDAC4 (0.67) HDAC4HDAC7HDAC5TSHRLMNA
SCHEMBL1075110 0.76 HDAC4 (0.50) HDAC4HDAC7HDAC5TSHRCYP3A4
SCHEMBL14491000 0.76 HDAC4 (0.60) HDAC4HDAC7HDAC5TSHRMAPK1
SCHEMBL2218308 0.72 HDAC4 (0.55) HDAC4HDAC7HDAC5ALDH1A1LMNA
SCHEMBL7795339 0.71 HDAC4 (0.51) HDAC4HDAC7HDAC5TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626447-B1 Monoclonal antibodies and Fv specific for cd2 antigen BRISTOL MYERS SQUIBB CO (US) 2005-10-05 EP disclosed
US-6384198-B1 SELECTING AND ISOLATING PERIPHERAL BLOOD MONONUCLEAR CELLS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS, THEN CONTACTING WITH SPECIFIC ANTIBODY OR LIGAND WHICH PREVENTS PRODUCTION OF VIRUS IN T CELLS; VIRICIDES BRISTOL-MYERS SQIBB COMPANY 2002-05-07 US disclosed
US-5807734-A POLYPEPTIDE BRISTOL-MYERS SQUIBB COMPANY (US) 1998-09-15 US disclosed
US-5795572-A Monoclonal antibodies and FV specific for CD2 antigen BRISTOL-MYERS SQUIBB COMPANY (US) 1998-08-18 US disclosed
US-5783699-A MAY BE CONJUGATED TO ANTIGENS, HAPTENS, ANTIBODIES IN IMMUNOASSAYS ABBOTT LABORATORIES (US) 1998-07-21 US disclosed
US-5669819-A IMMUNOASSAY ABBOTT LABORATORIES (US) 1997-09-23 US disclosed
US-5565570-A REACTING AMINE WITH SULFONYL HALIDE IN INERT SOLVENT IN PRESENCE OF BASE TO FORM METAL SALT OF SULFONAMIDE, ACYLATING WITH ACTIVATED PHENANTHRIDINE-6-CARBOXYLIC ACID TO FORM CHEMILUMINESCENT SALT ABBOTT LABORATORIES (US) 1996-10-15 US disclosed
US-5545739-A E.G., 5-METHYL-6-(N-2-CARBOXYETHYL-N=(2-CARBOXYETHYL)-PHENANTHRIDIN IUMCARBOXAMIDE CHLORIDE; IMMUNOASSAYS; STABILITY; SENSITIVITY ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5543524-A FORMING A SULFONAMIDE FROM AND AMINE AND A SULFONYL HALIDE AND AND ACYLATING WITH A CARBONYL HALIDE OF AN ACTIVATED ACRIDINE SALT ABBOTT LABORATORIES (US) 1996-08-06 US disclosed
US-5468646-A Chemiluminescent acridinium salts ABBOTT LABORATORIES (US) 1995-11-21 US disclosed
EP-0626447-A1 Monoclonal antibodies and Fv specific for cd2 antigen Bristol-Myers Squibb Company (US) 1994-11-30 EP disclosed
EP-0273115-B1 Chemiluminescent acridinium and phenanthridinium salts ABBOTT LAB (US) 1994-09-07 EP disclosed
EP-0511366-A1 CHEMILUMINESCENT COMPOUNDS BECKMAN INSTRUMENTS, INC. (US) 1992-11-04 EP disclosed
WO-1992009580-A1 CHEMILUMINESCENT COMPOUNDS BECKMAN INSTRUMENTS, INC. (US) 1992-06-11 WO disclosed
EP-0273115-A2 Chemiluminescent acridinium and phenanthridinium salts ABBOTT LABORATORIES (US) 1988-07-06 EP disclosed